STOCK TITAN

[Form 4] Regis Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Michelle St. DeVore, Senior Vice President, Marketing at Regis Corporation (RGS), reported an award-based acquisition of 2,500 shares of Regis common stock on 09/05/2025. The transaction price is reported as $0, indicating a grant rather than an open-market purchase. Following the reported transaction, the reporting person beneficially owns 5,000 shares. The award vests in three equal annual tranches: one-third on each of the first, second, and third anniversaries of the grant date, subject to continued employment and the grant terms. The Form 4 was signed by power-of-attorney on 09/09/2025.

Michelle St. DeVore, Senior Vice President Marketing presso Regis Corporation (RGS), ha registrato un'acquisizione tramite premio di 2.500 azioni ordinarie di Regis in data 05/09/2025. Il prezzo della transazione è indicato come $0, segnalando una concessione e non un acquisto sul mercato aperto. Dopo l'operazione comunicata, la dichiarante detiene beneficiariamente 5.000 azioni. Il premio matura in tre tranche annuali uguali: un terzo al primo, secondo e terzo anniversario della data della concessione, subordinato alla continuità dell'impiego e ai termini della concessione. Il Modulo 4 è stato firmato per procura in data 09/09/2025.

Michelle St. DeVore, Vicepresidenta Senior de Marketing en Regis Corporation (RGS), informó la adquisición por concesión de 2.500 acciones ordinarias de Regis el 05/09/2025. El precio de la operación figura como $0, lo que indica una adjudicación y no una compra en el mercado abierto. Tras la transacción reportada, la persona informante posee beneficiariamente 5.000 acciones. La concesión vence en tres tramos anuales iguales: un tercio en el primer, segundo y tercer aniversario de la fecha de concesión, sujeto a la continuidad del empleo y a los términos de la concesión. El Formulario 4 fue firmado por poder el 09/09/2025.

Michelle St. DeVore님은 Regis Corporation(RGS) 마케팅 수석부사장으로서 2025-09-052,500주의 보통주를 보상형 취득으로 보고했습니다. 거래 가격은 $0로 기재되어 있어 장외 매수가 아닌 지분 부여임을 나타냅니다. 보고된 거래 후 해당 보고인은 총 5,000주를 실질적으로 보유하고 있습니다. 보상은 3년간 매년 균등하게 1/3씩(부여일의 1주년, 2주년, 3주년) 베스팅되며 계속 근무 및 부여 조건이 적용됩니다. Form 4는 2025-09-09에 위임장으로 서명되었습니다.

Michelle St. DeVore, Senior Vice President Marketing chez Regis Corporation (RGS), a déclaré une acquisition par attribution de 2 500 actions ordinaires de Regis le 05/09/2025. Le prix de la transaction est indiqué à 0 $, ce qui signifie une attribution et non un achat sur le marché ouvert. Après la transaction déclarée, la personne déclarante détient bénéficiairement 5 000 actions. L'attribution est acquise en trois tranches annuelles égales : un tiers à chaque premier, deuxième et troisième anniversaire de la date d'attribution, sous réserve de la poursuite de l'emploi et des conditions de l'attribution. Le Formulaire 4 a été signé par procuration le 09/09/2025.

Michelle St. DeVore, Senior Vice President Marketing bei Regis Corporation (RGS), meldete am 05.09.2025 den ertragsbasierten Erwerb von 2.500 Stammaktien von Regis. Der Transaktionspreis wird mit $0 angegeben, was auf eine Zuteilung und keinen Kauf am offenen Markt hinweist. Nach der gemeldeten Transaktion besitzt die meldende Person wirtschaftlich 5.000 Aktien. Die Zuteilung wird in drei gleich großen jährlichen Tranchen fällig: jeweils ein Drittel am ersten, zweiten und dritten Jahrestag des Zuteilungsdatums, vorbehaltlich fortbestehender Beschäftigung und der Zuteilungsbedingungen. Das Formular 4 wurde am 09.09.2025 per Vollmacht unterzeichnet.

Positive
  • Reporting compliance: Timely Form 4 filing documents the insider award and meets Section 16 disclosure requirements.
  • Alignment with long-term incentives: Award vests 1/3 annually over three years, tying compensation to continued employment and future performance.
Negative
  • None.

Insights

TL;DR: Insiders received 2,500 restricted shares; ownership rose to 5,000 shares, a routine compensation grant with time-based vesting.

The reported transaction is a standard equity compensation award rather than a market purchase. A grant of 2,500 shares that vests 1/3 annually aligns management incentives with shareholder value over a three-year horizon. Because the price is reported as $0, this appears to be a restricted stock award or similar form of compensation. For investors, the event is not dilutive at a material level absent information about total outstanding shares or other concurrent grants. This is a routine disclosure required under Section 16.

TL;DR: The filing documents a time-based equity grant to an officer; governance implications are routine and limited.

The filing shows compliance with Section 16 reporting for an officer-level restricted share award. Vesting over three anniversaries is a common retention mechanism. There are no indications of accelerated vesting, related-party transactions, or changes in control provisions disclosed in this Form 4. The disclosure is standard practice and does not by itself indicate governance concerns or extraordinary compensation arrangements.

Michelle St. DeVore, Senior Vice President Marketing presso Regis Corporation (RGS), ha registrato un'acquisizione tramite premio di 2.500 azioni ordinarie di Regis in data 05/09/2025. Il prezzo della transazione è indicato come $0, segnalando una concessione e non un acquisto sul mercato aperto. Dopo l'operazione comunicata, la dichiarante detiene beneficiariamente 5.000 azioni. Il premio matura in tre tranche annuali uguali: un terzo al primo, secondo e terzo anniversario della data della concessione, subordinato alla continuità dell'impiego e ai termini della concessione. Il Modulo 4 è stato firmato per procura in data 09/09/2025.

Michelle St. DeVore, Vicepresidenta Senior de Marketing en Regis Corporation (RGS), informó la adquisición por concesión de 2.500 acciones ordinarias de Regis el 05/09/2025. El precio de la operación figura como $0, lo que indica una adjudicación y no una compra en el mercado abierto. Tras la transacción reportada, la persona informante posee beneficiariamente 5.000 acciones. La concesión vence en tres tramos anuales iguales: un tercio en el primer, segundo y tercer aniversario de la fecha de concesión, sujeto a la continuidad del empleo y a los términos de la concesión. El Formulario 4 fue firmado por poder el 09/09/2025.

Michelle St. DeVore님은 Regis Corporation(RGS) 마케팅 수석부사장으로서 2025-09-052,500주의 보통주를 보상형 취득으로 보고했습니다. 거래 가격은 $0로 기재되어 있어 장외 매수가 아닌 지분 부여임을 나타냅니다. 보고된 거래 후 해당 보고인은 총 5,000주를 실질적으로 보유하고 있습니다. 보상은 3년간 매년 균등하게 1/3씩(부여일의 1주년, 2주년, 3주년) 베스팅되며 계속 근무 및 부여 조건이 적용됩니다. Form 4는 2025-09-09에 위임장으로 서명되었습니다.

Michelle St. DeVore, Senior Vice President Marketing chez Regis Corporation (RGS), a déclaré une acquisition par attribution de 2 500 actions ordinaires de Regis le 05/09/2025. Le prix de la transaction est indiqué à 0 $, ce qui signifie une attribution et non un achat sur le marché ouvert. Après la transaction déclarée, la personne déclarante détient bénéficiairement 5 000 actions. L'attribution est acquise en trois tranches annuelles égales : un tiers à chaque premier, deuxième et troisième anniversaire de la date d'attribution, sous réserve de la poursuite de l'emploi et des conditions de l'attribution. Le Formulaire 4 a été signé par procuration le 09/09/2025.

Michelle St. DeVore, Senior Vice President Marketing bei Regis Corporation (RGS), meldete am 05.09.2025 den ertragsbasierten Erwerb von 2.500 Stammaktien von Regis. Der Transaktionspreis wird mit $0 angegeben, was auf eine Zuteilung und keinen Kauf am offenen Markt hinweist. Nach der gemeldeten Transaktion besitzt die meldende Person wirtschaftlich 5.000 Aktien. Die Zuteilung wird in drei gleich großen jährlichen Tranchen fällig: jeweils ein Drittel am ersten, zweiten und dritten Jahrestag des Zuteilungsdatums, vorbehaltlich fortbestehender Beschäftigung und der Zuteilungsbedingungen. Das Formular 4 wurde am 09.09.2025 per Vollmacht unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DeVore Michelle St. Lawrence

(Last) (First) (Middle)
3701 WAYZATA BLVD

(Street)
MINNEAPOLIS MN 55416

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REGIS CORP [ RGS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Marketing
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2025 A 2,500(1) A $0 5,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The award vests as to 1/3 of the shares on the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued employment with the Issuer through such anniversaries and the other terms and conditions of the grant agreements.
/s/ Amy Seidel, by power-of-attorney 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Michelle St. DeVore report on Form 4 for RGS?

The filing reports an acquisition of 2,500 shares on 09/05/2025 and total beneficial ownership of 5,000 shares following the transaction.

Was the 2,500-share transaction a purchase or a grant?

The transaction price is reported as $0, indicating an equity grant (restricted stock or similar) rather than an open-market purchase.

How does the award vest according to the Form 4?

The award vests 1/3 of the shares on each of the first, second, and third anniversaries of the grant date, subject to continued employment and grant terms.

What is Michelle St. DeVore's role at Regis Corporation noted in the filing?

She is listed as SVP, Marketing and is an officer of the issuer.

When was the Form 4 signed and by whom?

The Form 4 was signed by power-of-attorney Amy Seidel on 09/09/2025.
Regis Corp

NASDAQ:RGS

RGS Rankings

RGS Latest News

RGS Latest SEC Filings

RGS Stock Data

64.70M
1.98M
14.27%
30.96%
3.77%
Personal Services
Services-personal Services
Link
United States
MINNEAPOLIS